- Review Article
- Published:
Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
Nature Reviews Molecular Cell Biologyvolume 9, pages759–769 (2008)Cite this article
7301Accesses
9Altmetric
ACorrigendum to this article was published on 01 December 2008
Key Points
Ataxia-telangiectasia (A-T) is a rare human genetic disorder that is characterized by cancer predisposition, neurodegeneration, immunodeficiency, radiosensitivity, chromosomal instability and cell-cycle checkpoint defects.
A-T mutated (ATM) protein is a member of the phosphoinositide 3-kinase (PI3K)-related protein kinase (PIKK) family of protein kinases and has a central role in the response to DNA double-strand breaks (DSBs).
ATM responds to breaks introduced by DNA-damaging agents and to physiologically induced breaks.
ATM is activated by dissociation of an inactive dimer to form an active monomeric form of the protein.
Autophosphorylation and acetylation contribute to ATM activation.
Partial activation of ATM occurs in response to agents that alter chromatin structure, and full activation is achieved when it is recruited to the MRE11–RAD50–NBS1 (MRN) complex at the break site.
Recruitment of ATM to a DNA DSB occurs as part of an assembly complex with other proteins, including H2AX, MDC1, RNF8 and BRCA1.
The MRN complex assists in the activation of ATM and in time becomes a substrate (through NBS1) for active ATM.
Once activated, ATM phosphorylates a multitude of substrates that are involved in cell-cycle checkpoint activation and DNA repair. The MRN complex has an adaptor role, at least in the case of some of these substrates.
Abstract
First described over 80 years ago, ataxia-telangiectasia (A-T) was defined as a clinical entity 50 years ago. Although not encountered by most clinicians, it is a paradigm for cancer predisposition and neurodegenerative disorders and has a central role in our understanding of the DNA-damage response, signal transduction and cell-cycle control. The discovery of the protein A-T mutated (ATM) that is deficient in A-T paved the way for rapid progress on understanding how ATM functions with a host of other proteins to protect against genome instability and reduce the risk of cancer and other pathologies.
This is a preview of subscription content,access via your institution
Access options
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Boder, E. Ataxia-telangiectasia: an overview.Kroc. Found. Ser.19, 1–63 (1985).An excellent description of the clinical phenotype in A-T particularly for the neurological defects.
Syllaba, K. & Henner, K. Contribution a l'independence de l'athetose double idiopathique et congenitale. Atteinte familiale, syndrome dystrophique, signe de reseau vasculaire conjonctival, integrite psychique.Rev. Neurol.1, 541–562 (1926) (in French).
Boder, E. & Sedgwick, R. P. Ataxia-telangiectasia. A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. A preliminary report on 7 children, an autopsy, and a case history.Univ. S. Calif. Med. Bull.9, 15–28 (1957).
Lavin, M. F. & Shiloh, Y. The genetic defect in ataxia-telangiectasia.Annu. Rev. Immunol.15, 177–202 (1997).A comprehensive early review on A-T and the cloning and characteristics of theATM gene.
Gatti, R. A. et al. Localization of an ataxia-telangiectasia gene to chromosome 11q22–23.Nature336, 577–580 (1988).
Savitsky, K. et al. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase kinase.Science.268, 1749–1753 (1995).Describes the identification of theATM gene, which is defective in A-T.
Brumbaugh, K. M. et al. The mRNA surveillance protein hSMG-1 functions in genotoxic stress response pathways in mammalian cells.Mol. Cell14, 585–598 (2004).
Yamashita, A. et al. Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay.Genes Dev.15, 2215–2228 (2001).
Banin, S. et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage.Science281, 1674–1677 (1998).
Canman, C. E. et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.Science281, 1677–1679 (1998).
Khanna K. K. et al. ATM associates with and phosphorylates p53: mapping the region of interaction.Nature Genet.20, 398–400 (1998).References 9–11 identified the first substrate for ATM, p53.
Kastan, M. B. et al. A mammalian cell cycle checkpoint pathway utilising p53 and GADD45 is defective in ataxia-telangiectasia.Cell71, 587–597 (1992).Description of a radiation-induced pathway that connects p53 with the A-T gene product.
Khanna, K. K. & Lavin, M. F. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells.Oncogene8, 3307–3312 (1993).
Matsuoka, S. et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.Science316, 1160–1166 (2007).
Linding, R. et al. Systematic discovery ofin vivo phosphorylation networks.Cell129, 1415–1426 (2007).
Bosotti, R., Isacchi, A. & Sonnhammer, E. L. FAT: a novel domain in PIK-related kinases.Trends Biochem. Sci.25, 225–227 (2000).
Shafman, T. et al. Interaction between ATM protein and c-Abl in response to DNA damage.Nature387, 520–523 (1997).ABL kinase is identified as an ATM interacting protein. See also reference 116.
Carney, J. P. et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response.Cell93, 477–486 (1998).
Matsuura, S. et al. Positional cloning of the gene for Nijmegen breakage syndrome.Nature Genet.19, 179–181 (1998).
Varon, R. et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome.Cell93, 467–476 (1998).
Stewart, G. S. et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder.Cell99, 577–587 (1999).
Houldsworth, J. & Lavin, M. F. Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia cells.Nucleic Acids Res.8, 3709–3720 (1980).First description of a cell-cycle checkpoint defect (radioresistant DNA synthesis) in A-T cells. See also reference 23.
Painter, R. B. & Young, B. R. Radiosensitivity in ataxia-telangiectasia: a new explanation.Proc. Natl Acad. Sci. USA77, 7315–7317 (1980).
Beamish, H. & Lavin, M. F. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay.Int. J. Radiat. Biol.65, 175–184 (1994).
Scott, D. & Zampetti-Bosseler, F. Cell cycle dependence of mitotic delay in X-irradiated normal and ataxia-telangiectasia fibroblasts.Int. J. Radiat. Biol.42, 679–683 (1982).
Jaspers, N. G. & Bootsma, D. Abnormal levels of UV-induced unscheduled DNA synthesis in ataxia telangiectasia cells after exposure to ionizing radiation.Mutat. Res.1–2, 439–446 (1982).
Lange, E. et al. Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium.Am. J. Hum. Genet.1, 112–119 (1995).
Savitsky, K. et al. The complete sequence of the coding region of theATM gene reveals similarity to cell cycle regulators in different species.Hum. Mol. Genet.4, 2025–2032 (1995).
Uziel, T. et al. Genomic organization of theATM gene.Genomics2, 317–320 (1996).
Chun, H. H. & Gatti, R. A. Ataxia-telangiectasia, an evolving phenotype.DNA Repair3, 1187–1196 (2004).
Gotoff, S. P., Amirmokri, E. & Liebner, E. J. Ataxia-telangiectasia. Neoplasia, untoward response to X-irradiation, and tuberous sclerosis.Am. J. Dis. Child.114, 617–625 (1967).
Taylor, A. M. et al. Ataxia-telangiectasia: a human mutation with abnormal radiation sensitivity.Nature4, 427–429 (1975).
Chen, P. C., Lavin, M. F., Kidson, C. & Moss, D. Identification of ataxia telangiectasia heterozygotes, a cancer prone population.Nature274, 484–486 (1978).
Riballo, E. et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to γ-H2AX foci.Mol. Cell16, 715–724 (2004).
Foray, N. et al. Hypersensitivity of ataxia telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks.Int. J. Radiat. Biol.72, 271–283 (1997).
Kuhne, M., Rothkamm, K. & Lobrich, M. No dose-dependence of DNA double-strand break misrejoining following alpha-particle irradiation.Int. J. Radiat. Biol.76, 891–900 (2000).
Goodarzi, A. A. et al. ATM signalling facilitates repair of DNA double-strand breaks associated with heterochromatin.Mol. Cell31, 167–177 (2008).
Berkovich, E., Monnat, R. J. Jr, & Kastan, M. B. Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair.Nature Cell Biol.9, 683–690 (2007).A model system to investigate the series of events associated with ATM activation.
Yazdi, P. T. et al. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.Genes Dev.16, 571–582 (2002).
Kitagawa, R., Bakkenist, C. J., McKinnon, P. J. & Kastan, M. B. Phosphorylation of SMC1 is a critical downstream event in the ATM–NBS1–BRCA1 pathway.Genes Dev.18, 1423–1438 (2004).
Lumsden, J. M. et al. Immunoglobulin class switch recombination is impaired in Atm-deficient mice.J. Exp. Med.200, 1111–1121 (2004).
Bredemeyer, A. L. et al. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination.Nature442, 466–470 (2006).
Vecchio, M. S., Olaru, A., Livak, F. & Hodes, R. J. ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor α locus coding end breaks.Proc. Natl Acad. Sci. USA104, 6323–6328 (2007).
Perkins, E. J. et al. Sensing of intermediates V(D)J recombination by ATM.Genes Dev.16, 159–164 (2002).
Matei, I. R. et al. ATM deficiency disrupts TCRα locus integrity and the maturation of CD4+CD8+ thymocytes.Blood109, 1887–1896 (2007).
Lim, D. S. et al. ATM binds to β-adaptin in cytoplasmic vesicles.Proc. Natl Acad. Sci. USA.95, 10146–10151 (1998).
Watters, D. et al. Localization of a portion of extranuclear ATM to peroxisomes.J. Biol. Chem.274, 34277–34282 (1999).
Lavin, M. F. et al. inHandbook of Cell Signalling (eds Bradshaw R. A. and Dennis, E. A.) 225–236 (Academic, London, 2003).
Yang, D.Q. & Kastan, M. B. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1.Nature Cell Biol.2, 893–898 (2000).
Schlach, D. S., McFarlin, D. & Barlow, M. H. An unusual form of diabetes mellitus in ataxia telangiectasia.N. Engl. J. Med.282, 1396–1402 (1970).
Bar, R. S. et al. Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors.N. Engl. J. Med.298, 1164–1171 (1978).
Schneider, J. G. et al. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome.Cell. Metab.4, 377–389 (2006).
Bakkenist, C. J. & Kastan, M. B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.Nature421, 499–506 (2003).A major contribution to understanding the mechanism of ATM activation.
Barlow, C. et al. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation.Proc. Natl Acad. Sci. USA97, 871–876 (2000).
Biton, S. et al. ATM-mediated response to DNA double strand breaks in human neurons derived from stem cells.DNA Repair6, 128–134 (2006).
Dar, I. et al. Analysis of the ataxia telangiectasia mutated-mediated DNA damage response in murine cerebellar neurons.J. Neurosci.26, 7767–7674 (2006).
Taylor, A. M. R., Groom, A. & Byrd, P. J. Ataxia-telangiectasia-like disorder (ATLD) — its clinical presentation and molecular basis.DNA Repair.3, 1219–1225 (2004).
Cimprich, K. A. & Cortez, D. ATR: an essential regulator of genome integrity.Nature Rev. Mol. CellBiol.9, 616–627 (2008).
Huen, M. S. Y. & Chen, J. The DNA damage response pathways: at the crossroad of protein modifications.Cell Res.18, 8–16 (2008).
You, Z. et al. Rapid activation of ATM on DNA flanking double-strand breaks.Nature Cell Biol.9, 1311–1318 (2007).
de Jager, M. et al. Human Rad50/Mre11 is a flexible complex that can tether DNA ends.Mol. Cell8, 1129–1135 (2001).
van den Bosch, M., Bree, R. T. & Lowndes, N. F. The MRN complex: coordinating and mediating the response to broken chromosomes.EMBO Rep.4, 844–849 (2003).
Hopfner, K. P., Craig, L., Moncalian, G., Zinkel, R. A. et al. The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination repair.Nature418, 562–566 (2002).
Moreno-Herrero, F. et al. Mesoscale conformational changes in the DNA-repair complex Rad50/Mre11/Nbs1 upon binding DNA.Nature437, 440–443 (2005).
Paull, T. T. & Gellert, M. The 3′ to 5′ exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks.Mol. Cell1, 969–979 (1998).
Paull, T. T. & Gellert, M. Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex.Genes Dev.13, 1276–1288 (1999).
Mirzoeva, O. K. & Petrini, J. H. DNA replication-dependent nuclear dynamics of the Mre11 complex.Mol. Cancer Res.1, 207–218 (2003).
Uziel, T. et al. Requirement of the MRN complex for ATM activation by DNA damage.EMBO J.22, 5612–5621 (2003).Shows the importance of the MRN complex as an upstream activator of ATM.
Cerosaletti, K. & Concannon, P. Independent roles for nibrin and Mre11–Rad50 in the activation and function of Atm.J. Biol. Chem.279, 38813–38819 (2004).
Digweed, M., Reis, A. & Sperling, K. Nijmegen breakage syndrome: consequences of defective DNA double strand break repair.Bioessays21, 649–656 (1999).
Falck, J., Coates, J. & Jackson, S. P. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage.Nature434, 605–611 (2005).Describes a role for NBS1 in the recruitment of ATM to sites of DNA damage.
Cerosaletti, K., Wright, J. & Concannon, P. Active role for nibrin in the kinetics of ATM activation.Mol. Cell. Biol.26, 1691–1699 (2005).
Kozlov, S. V. et al. Involvement of novel autophosphorylation sites in ATM activation.EMBO J.25, 3504–3514 (2006).
Goodarzi, A. A., et al. Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A.EMBO J.23, 4451–4461 (2004).
Shreeram, S. et al. Wip1 phosphatase modulates ATM-dependent signalling pathways.Mol. Cell23, 757–764 (2006).
Ali, A., et al. Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation.Genes Dev.18, 249–254 (2004).
Sun, Y. et al. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM.Proc. Natl Acad. Sci. USA102, 13182–13187 (2005).
Sun, Y. et al. DNA damage-induced acetylation of lysine 3016 of ATM activates ATM kinase activity.Mol. Cell. Biol.27, 8502–8509 (2007).
Pellegrini, M. et al. Autophosphorylation at serine 1987 is dispensable for murine Atm activationin vivo.Nature443, 222–225 (2006).Describes a mouse model that questions the importance of autophosphorylation in ATM activation.
Hamer, G. et al. Ataxia telangiectasia mutated expression and activation of the testis.Biol. Reprod.70, 1206–1212 (2004).
Powers, J. T. et al. E2F1 uses the ATM signalling pathway to induce p53 and Chk2 phosphorylation and apoptosis.Mol. Cancer Res.2, 203–214 (2004).
Kurz, E. U., Douglas, P. & Lees-Miller, S. Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species.J. Biol. Chem.279, 53272–53281 (2004).
Shiloh, Y. The ATM-mediated DNA-damage response: taking shape.Trends Biochem. Sci.31, 402–410 (2006).
Beausoleil, S. A. et al. Large-scale characterisation of HeLa cell nuclear phosphoproteins.Proc. Natl Acad. Sci. USA101, 12130–12135 (2004).
Lukas, C. et al. Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention.EMBO J.23, 2674–2683 (2004).
Jacob, N. K., Stout, A. R. & Price, C. M. Modulation of telomere length dynamics by the subtelomeric region of tetrahymena telomeres.Mol. Biol. Cell15, 3719–3728 (2004).
Bassing, C. H. et al. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.Cell114, 359–370 (2003).
Celeste, A. et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility.Cell114, 371–383 (2003).
Stucki, M. & Jackson, S. P. MDC1/NFBD1: A key regulator of the DNA damage response in higher eukaryotes.DNA Repair3, 953–957 (2004).
Chapman, J. R. & Jackson, S. P. Phospho-dependent interactions between Nbs1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage.EMBO Rep.9, 795–801 (2008).
Melander, F. et al. Phosphorylation of SDT repeats in the MDC1 N terminus triggers retention of NBS1 at the DNA damage-modified chromatin.J. Cell Biol.181, 213–226 (2008).
Huen, M. S. et al. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly.Cell131, 901–914 (2007).
Kolas, N. K. et al. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase.Science318, 1637–1640 (2007).
Mailand, N. et al. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins.Cell131, 887–900 (2007).
Lavin, M. F. ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks.Oncogene26, 7749–7758 (2007).
Buscemi, G. et al. Chk2 activation dependence on Nbs1 after DNA damage.Mol. Cell. Biol.21, 5214–5222 (2001).
Nakanishi, K. et al. Interaction of FANCD2 and NBS1 in the DNA damage response.Nature Cell Biol.4, 913–920 (2002).
Gatei, M. et al. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation.J. Biol. Chem.278, 14806–14811 (2003).
Spycher, C. et al. Constitutive phosphorylation of MDC1 physically links the Mre11–Rad50–Nbs1 complex to damaged chromatin.J. Cell Biol.181, 227–240 (2008).
Lou, Z., et al. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals.Mol. Cell21, 187–200 (2006).
Lukas, C. et al. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage.Nature Cell Biol.5, 255–260 (2003).Describes the use of microlasers to determine the order at which DNA-damage response proteins are recruited to chromatin.
Bekker-Jensen, S. et al. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks.J. Cell Biol.173, 195–206 (2006).
Zhao, S. et al. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products.Nature405, 473–477 (2000).
Wu, X. et al. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response.Nature405, 477–482 (2000).
Gatei, M., Young, D., Cerosaletti, K. M., Desai-Mehta, A. et al. ATM-dependent phosphorylation of nibrin in response to radiation exposure.Nature Genet.25, 115–119 (2000).
Lim, D. S. et al. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.Nature404, 613–617 (2000).
Lee, J. H. et al. Regulation of Mre11/Rad50 by Nbs1: effects on nucleotide-dependent DNA binding and association with ataxia-telangiectasia-like disorder mutant complexes.J. Biol. Chem.278, 45171–45178 (2003).
Falck, J., Petrini, J. H., Williams, B. R., Lukas, J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways.Nature Genet.30, 290–294 (2002).
Lee, J. H. & Paull, T. T. ATM activation by DNA double-strand breaks through the Mre11–Rad50–Nbs1 complex.Science308, 551–554 (2005).
Soutoglou, E. & Misteli, T. Activation of the cellular DNA damage response in the absence of DNA lesions.Science320, 1507–1510 (2008).
Halazonetis, T. D., Gorgoulis, V. G. & Bartek, J. An oncogene-induced DNA damage model for cancer development.Science319, 1352–1355 (2008).
Swift, M., Morrell, D., Massey, R. B. & Chase, C. L. Incidence of cancer in 161 families affected by ataxia-telangiectasia.N. Engl. J. Med.325, 1831–1836 (1991).First comprehensive report on increased cancer incidence in A-T heterozygotes in particular breast cancers.
Renwick, A. et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.Nature Genet.38, 873–875 (2008).
Kim, S. T., Lim, D. S., Canman, C. E. & Kastan, M. B. Substrate specificities and identification of putative substrates of ATM kinase family members.J. Biol. Chem.274, 37538–37543 (1999).
O'Neill, T. et al. Utilisation of oriented peptide libraries to identify substrate motifs selected by ATM.J. Biol. Chem.275, 22719–22727 (2000).
Petersen, R., Kelly D. & Good, R. A. Ataxia-telangiectasia: its association with a defective thymus, immunological deficiency disease and malignancy.Lancet1, 1189–1193 (1964).
Spector, B. D., Filipovich, A. H., Perry, G.S. & Kersey, H. inAtaxia-Telangiectasia (eds Bridges, B. A. & Harnden, D. G.) 103–141 (John Wiley & Sons, 1982).
Cornforth, M. N. & Bedford, J. S. On the nature of a defect in cells from individuals with ataxia-telangiectasia.Science1, 1589–1591 (1985).Describes the defective gene in A-T which is localized to chromosome 11q.
Baskaran, R. et al. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation.Nature387, 516–519 (1997).
Smith, G. C. et al. Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM.Proc. Natl Acad. Sci. USA.96, 11134–11139 (1999).
Chan, D. W. et al. Purification and characterisation of ATM from human placenta. A manganese-dependent, wortmannin-sensitive serine/threonine protein kinase.J. Biol. Chem.275, 7803–7810 (2000).
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P. et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.Nature444, 633–637 (2006).
Gougoulis, V. G., Vassiliou, L. V., Karakaidos, P., Zacharatos, P. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.Nature434, 907–913 (2005).
Author information
Authors and Affiliations
Radiation Biology and Oncology Laboratory, Queensland Institute of Medical Research, Brisbane, QLD 4029, Australia and the University of Queensland, Centre for Clinical Research, Brisbane, QLD 4029, Australia. martin.lavin@qimr.edu.au,
Martin F. Lavin
- Martin F. Lavin
You can also search for this author inPubMed Google Scholar
Related links
Glossary
- Checkpoint
In this example, a cell-cycle checkpoint is a control mechanism to ensure that chromosomes are intact for cell division.
- Adaptor
A protein that assists in the process of downstream signalling. In this case, NBS1 has an adaptor role in ATM signalling.
- Radioresistant DNA synthesis
The absence of a steep component of inhibition of DNA synthesis in a dose–response curve when the rate of DNA synthesis is plotted against radiation doses.
- Complementation group
This refers to previous studies on A-T cells in which cell fusion was used to determine whether more than one protein was involved in the defect.
- Non-homologous end joining (NHEJ) repair
The repair of DNA double-strand breaks (free ends) by DNA-PK and other cofactors without the requirement for DNA recombination.
- Heterochromatin
A cytologically distinct, tightly packed form of chromatin in which transcription is repressed.
- V(D)J recombination
A mechanism that involves gene rearrangement in the maturation of immunoglobulin and T-cell receptor genes.
- Peroxisomes
Subcellular organelles that metabolize fatty acids and clear the cell of toxic peroxides.
- Endosomes
Vesicles derived from the plasma membrane to transport proteins and other substances into the cell.
- Purkinje cell
Neuronal cells found on the cerebellum between the molecular and granular layers.
- Autophosphorylation
The process by which a protein kinase uses itself as a substrate for phosphorylation in many cases for self-activation.
- Downstream signalling
Part of a signal transduction pathway in which a protein, such as ATM, phosphorylates a series of substrates that assist in controlling various cellular processes.
- FHA domain
(Forkhead-associated domain). A short sequence of amino acids that binds to phosphothreonine residues on various proteins.
- ATPase domain
The region of a protein that is responsible for the hydrolysis of ATP and is coupled to protein phosphorylation.
- Exonuclease
The enzyme that degrades nucleic acids from 3′ to 5′ free ends.
- Endonuclease
An enzyme that is capable of hydrolysing phosphodiester bonds in nucleic acids that are away from the free ends.
- Ubiquitylation
Post-translational modification of a protein by the covalent attachment of a ubiquitin protein to enable degradation or other forms of regulation.
Rights and permissions
About this article
Cite this article
Lavin, M. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer.Nat Rev Mol Cell Biol9, 759–769 (2008). https://doi.org/10.1038/nrm2514
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
